The civic record
Read. Follow. Verify.Utah Bill Automatically Reschedules Psilocybin If Federal Government Reclassifies It
Last action · March 6, 2026: Senate/ filedSponsor: Kirk Cullimore
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Utah SB 114 provides for the automatic rescheduling of a specific pharmaceutical composition of if the federal government moves it out of Schedule I, effective May 6, 2026.
Changes state-level drug scheduling alignment for psilocybin, tying Utah's classification directly to future federal regulatory actions without requiring separate state legislative updates.
- State controlled substances acts establish schedules (I through V) that categorize drugs according to their medical utility and potential for abuse, mirroring or interacting with federal schedules under the Controlled Substances Act. context
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
Medical and Pharmaceutical Providers
Providers face altered state-level legal classifications and prescribing rules for crystalline polymorph psilocybin if federal rescheduling occurs.
Law Enforcement Agencies
Enforcement agencies must adhere to automatically updated state scheduling categories that mirror federal changes for psilocybin.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · in Senate committee.
Procedural history
15 actions- Mar 6, 2026SenateSenate/ filed
- Mar 6, 2026SenateSenate/ strike enacting clause
- Mar 3, 2026SenateSenate/ comm rpt/ sent to Rules
- Mar 2, 2026SenateSenate Comm - Recommends Returned to Rules
- Jan 21, 2026SenateSenate Comm - Not Considered
- Jan 20, 2026SenateCommitteeSenate/ to standing committee
Show 9 earlier actions
- Jan 20, 2026SenateIntroducedSenate/ 1st reading (Introduced)
- Jan 19, 2026SenateSenate/ received fiscal note from Fiscal Analyst
- Jan 17, 2026ReleasedLFA/ fiscal note publicly available for SB0114
- Jan 17, 2026Version SponsorLFA/ fiscal note sent to sponsor for SB0114
- Jan 13, 2026SenateSenate/ received bill from Legislative Research
- Jan 9, 2026Legislative Fiscal AgencyLFA/ bill sent to agencies for fiscal input for SB0114
- Jan 9, 2026Legislative Fiscal AnalystLFA/ bill assigned to staff for fiscal analysis for SB0114
- Jan 9, 2026Legislative Research and General CounselNumbered Bill Publicly Distributed
- Jan 9, 2026Legislative Research and General CounselBill Numbered but not Distributed
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Conditional State-Federal Drug Scheduling Alignment
The bill introduces a conditional mechanism that automatically ties state drug scheduling to future federal decisions for a specific psilocybin composition.
Connected Entities
Sources
le.utah.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 40)
- Controversy35Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz25Current news / social attention level
Publisher tools